Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / People / Matt Kapusta
Person

Matt Kapusta

Tracked across 2 events · 32 articles · First seen Mar 10, 2026 · Last active May 14, 2026

Sentiment
-70
Attention
6
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 -70
Regulatory
UniQure FDA Dispute and Lawsuit
Impact: Matt Kapusta, CEO of UniQure, is mentioned for describing the United States — Food and Drug Administration's sham surgery requirement as a 'drastic change' from previous guidance, which the United States — Food and Drug Administration disputed.
Apr 01, 2026 · 25 articles
6 -70
Regulatory
United States Food and Drug Administration Rebukes uniQure
Impact: Matt Kapusta, CEO of UniQure, described the United States — Food and Drug Administration's sham surgery requirement as a 'drastic change' from previous guidance, which the United States — Food and Drug Administration official disputed.
Mar 10, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Matt Kapusta live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.